| EQUITY |
EQUITY The following tables present the changes in consolidated equity (dollars in millions, share amounts in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Common Stock | | Additional Paid-In Capital | | Accumulated Other Comprehensive Loss | | Retained Earnings | | Treasury Stock | | Noncontrolling Interests | | Total Equity | | | | | | | Shares Outstanding | | Issued Par Amount | | | | | | | | | | | | Balances at December 31, 2025 | | 86,952 | | | $ | 8 | | | $ | 4,914 | | | $ | (181) | | | $ | 4,415 | | | $ | (4,936) | | | $ | 1,797 | | | $ | 6,017 | | | | | | | Net income | | — | | | — | | | — | | | — | | | 702 | | | — | | | 93 | | | 795 | | | | | | | Distributions paid to noncontrolling interests | | — | | | — | | | — | | | — | | | — | | | — | | | (75) | | | (75) | | | | | | | Other comprehensive income | | — | | | — | | | — | | | 2 | | | — | | | — | | | — | | | 2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Purchases of businesses and noncontrolling interests, net | | — | | | — | | | 270 | | | — | | | — | | | — | | | 84 | | | 354 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Repurchases of common stock | | (1,346) | | | — | | | — | | | — | | | — | | | (320) | | | — | | | (320) | | | | | | | Stock-based compensation expense, tax benefit and issuance of common stock | | 518 | | | — | | | (60) | | | — | | | — | | | — | | | — | | | (60) | | | | | | | Balances at March 31, 2026 | | 86,124 | | | 8 | | | 5,124 | | | (179) | | | 5,117 | | | (5,256) | | | 1,899 | | | 6,713 | | | | | | | Net income | | — | | | — | | | — | | | — | | | 826 | | | — | | | 106 | | | 932 | | | | | | | Distributions paid to noncontrolling interests | | — | | | — | | | — | | | — | | | — | | | — | | | (78) | | | (78) | | | | | | | Other comprehensive income | | — | | | — | | | — | | | 2 | | | — | | | — | | | — | | | 2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Purchases (sales) of businesses and noncontrolling interests, net | | — | | | — | | | 22 | | | — | | | — | | | — | | | (28) | | | (6) | | | | | | | Repurchases of common stock | | (5,675) | | | — | | | — | | | — | | | — | | | (1,052) | | | — | | | (1,052) | | | | | | | | | | | | | | | | | | | | | | | | | | | | Stock-based compensation expense, tax benefit and issuance of common stock | | 58 | | | — | | | 46 | | | — | | | — | | | — | | | — | | | 46 | | | | | | | Balances at June 30, 2026 | | 80,507 | | | $ | 8 | | | $ | 5,192 | | | $ | (177) | | | $ | 5,943 | | | $ | (6,308) | | | $ | 1,899 | | | $ | 6,557 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Common Stock | | Additional Paid-In Capital | | Accumulated Other Comprehensive Loss | | Retained Earnings | | Treasury Stock | | Noncontrolling Interests | | Total Equity | | | Shares Outstanding | | Issued Par Amount | | | | | | | | Balances at December 31, 2024 | | 95,109 | | | $ | 8 | | | $ | 4,873 | | | $ | (180) | | | $ | 3,008 | | | $ | (3,538) | | | $ | 1,649 | | | $ | 5,820 | | | Net income | | — | | | — | | | — | | | — | | | 406 | | | — | | | 95 | | | 501 | | | Distributions paid to noncontrolling interests | | — | | | — | | | — | | | — | | | — | | | — | | | (89) | | | (89) | | | Other comprehensive income | | — | | | — | | | — | | | 2 | | | — | | | — | | | — | | | 2 | | | | | | | | | | | | | | | | | | | | Purchases (sales) of businesses and noncontrolling interests, net | | — | | | — | | | (35) | | | — | | | — | | | — | | | 41 | | | 6 | | | Repurchases of common stock | | (2,629) | | | — | | | — | | | — | | | — | | | (351) | | | — | | | (351) | | | | | | | | | | | | | | | | | | | | Stock-based compensation expense, tax benefit and issuance of common stock | | 405 | | | — | | | (12) | | | — | | | — | | | — | | | — | | | (12) | | | Balances at March 31, 2025 | | 92,885 | | | 8 | | | 4,826 | | | (178) | | | 3,414 | | | (3,889) | | | 1,696 | | | 5,877 | | | Net income | | — | | | — | | | — | | | — | | | 288 | | | — | | | 105 | | | 393 | | | Distributions paid to noncontrolling interests | | — | | | — | | | — | | | — | | | — | | | — | | | (83) | | | (83) | | | Other comprehensive income | | — | | | — | | | — | | | 1 | | | — | | | — | | | — | | | 1 | | | | | | | | | | | | | | | | | | | | Purchases of businesses and noncontrolling interests, net | | — | | | — | | | 10 | | | — | | | — | | | — | | | 9 | | | 19 | | | Repurchases of common stock | | (4,601) | | | — | | | — | | | — | | | — | | | (753) | | | — | | | (753) | | | | | | | | | | | | | | | | | | | | Stock-based compensation expense, tax benefit and issuance of common stock | | 60 | | | — | | | 22 | | | — | | | — | | | — | | | — | | | 22 | | | Balances at June 30, 2025 | | 88,344 | | | $ | 8 | | | $ | 4,858 | | | $ | (177) | | | $ | 3,702 | | | $ | (4,642) | | | $ | 1,727 | | | $ | 5,476 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Nonredeemable Noncontrolling Interests The table below presents our nonredeemable noncontrolling interests balances by segment: | | | | | | | | | | | | | | | | | | June 30, 2026 | | December 31, 2025 | | Hospital Operations | | $ | 214 | | | $ | 211 | | | Ambulatory Care | | 1,685 | | | 1,586 | | | Total nonredeemable noncontrolling interests | | $ | 1,899 | | | $ | 1,797 | |
The table below presents our net income available to nonredeemable noncontrolling interests by segment: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | | 2026 | | 2025 | | 2026 | | 2025 | | Hospital Operations | | $ | 9 | | | $ | 12 | | | $ | 19 | | | $ | 24 | | | Ambulatory Care | | 97 | | | 93 | | | 180 | | | 176 | | | Total net income available to nonredeemable noncontrolling interests | | $ | 106 | | | $ | 105 | | | $ | 199 | | | $ | 200 | |
Share Repurchase Program Activity In July 2024, our board of directors authorized the repurchase of up to $1.500 billion of our common stock through a share repurchase program that has no expiration date. In July 2025, the board authorized a $1.500 billion increase to the program, and, in June 2026, the board authorized an additional $2.000 billion for share repurchases under the program. The share repurchase program does not obligate us to acquire any particular amount of common stock, and it may be suspended for periods or discontinued at any time. Share repurchases may be made in open‑market or privately negotiated transactions, at management’s discretion subject to market conditions and other factors, in a manner consistent with applicable securities laws and regulations. The table below presents repurchase activity under our share repurchase program: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Period | | | | Total Number of Shares Purchased | | Average Price Paid per Share | | Total Number of Shares Purchased as Part of Publicly Announced Program | | Maximum Dollar Value of Shares That May Yet Be Purchased Under the Program | | | | | | | (In Thousands) | | | | (In Thousands) | | (In Millions) | | | January 1 through June 30, 2026 | | | | | | | | | | | | | January 1 through January 31, 2026 | | | | — | | $ | — | | | — | | $ | 1,490 | | | | February 1 through February 28, 2026 | | | | — | | $ | — | | | — | | $ | 1,490 | | | | March 1 through March 31, 2026 | | | | 1,346 | | $ | 236.30 | | | 1,346 | | $ | 1,172 | | | | April 1 through April 30, 2026 | | | | — | | $ | — | | | — | | $ | 1,172 | | | | May 1 through May 31, 2026 | | | | 4,031 | | $ | 190.26 | | | 4,031 | | $ | 405 | | | | June 1 through June 30, 2026 | | | | 1,644 | | $ | 167.20 | | | 1,644 | | $ | 2,130 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | January 1 through June 30, 2025 | | | | | | | | | | | | | January 1 through January 31, 2025 | | | | — | | $ | — | | | — | | $ | 1,376 | | | | February 1 through February 28, 2025 | | | | 1,800 | | $ | 134.98 | | | 1,800 | | $ | 1,133 | | | | March 1 through March 31, 2025 | | | | 829 | | $ | 126.67 | | | 829 | | $ | 1,028 | | | | April 1 through April 30, 2025 | | | | — | | $ | — | | | — | | $ | 1,028 | | | | May 1 through May 31, 2025 | | | | 2,456 | | $ | 157.57 | | | 2,456 | | $ | 641 | | | | June 1 through June 30, 2025 | | | | 2,145 | | $ | 167.83 | | | 2,145 | | $ | 281 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|